Chronic subdural hematoma enhanced recovery pathway: targeting excellent outcomes

Srujana Venkata Vedicherla1, Zakir Hassan Chew1, Dave Thevandiran Kanavathy1

  • 11Department of Neurosurgery, National Neuroscience Institute, Singapore.

Neurosurgical Focus
|October 1, 2025
PubMed

Insights

Implementing an enhanced recovery pathway for chronic subdural hematoma (cSDH) surgery significantly reduced hospital length of stay and improved patient discharge destinations. This standardized care approach increased excellent outcomes for cSDH patients.

Area of Science:

  • Neurosurgery
  • Evidence-based medicine

Background:

  • Chronic subdural hematoma (cSDH) presents a common neurosurgical challenge.
  • Current surgical outcomes for cSDH, including recurrence and complication rates, require improvement.

Purpose of the Study:

  • To design and implement an enhanced recovery pathway for cSDH.
  • To evaluate the impact of this pathway on surgical outcomes.

Main Methods:

  • A multicenter cohort study compared outcomes before and after pathway implementation.
  • Patient data included demographics, clinical and radiological details.
  • Outcome measures: length of stay (LOS), complications, discharge location, mortality, and recurrence.

Main Results:

  • The post-pathway group showed a shorter median LOS (7 vs 9 days) and higher likelihood of discharge to home/rehab.
  • Excellent outcomes increased from 34.7% to 49.7% post-pathway.
  • Recurrence rates decreased, though not significantly (11.8% to 7.7%).

Conclusions:

  • Standardizing care via an enhanced recovery pathway improves LOS and discharge outcomes for cSDH.
  • This approach increases the proportion of patients achieving excellent outcomes.
  • Further research may explore strategies to significantly reduce recurrence rates.
Abstract